<DOC>
	<DOCNO>NCT01978223</DOCNO>
	<brief_summary>This study aim estimate effectiveness Rotarix™ vaccine Rotavirus severe gastroenteritis ( RV SGE ) among hospitalised child age 12 week &lt; 5 year , Venezuela ass current disease burden introduction vaccine .</brief_summary>
	<brief_title>Effectiveness RotarixTM Vaccine Children Aged Between 12 Weeks &lt; 5 Years , Hospitalised Severe Gastroenteritis</brief_title>
	<detailed_description>The data generate study useful public health officer policy maker confirm country-wide public health benefit Rotarix™ . No vaccine administer study .</detailed_description>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>For SGE subject : A male female child age 12 week &lt; 5 year time hospital admission/ ED stay . The subject become ineligible fifth birthday . Subject admit ( ED stay ) study hospital ( ) SGE study period . Onset SGE ≤ 14 day prior admission/ ED stay . Written/thumb print informed consent obtain parent ( ) /legally acceptable representative ( ) ( LAR ( ) ) subject . For Cases : • Laboratory confirm ( i.e . ELISA ) RVpositive stool sample collect hospital admission/ ED stay first 48 hour hospitalisation . For Controls : Subject admit ( ED stay ) study hospital ( ) SGE case study period . Laboratory confirm ( i.e . ELISA ) RVnegative stool sample collect hospital admission/ ED stay first 48 hour hospitalisation . Subjects bear within ± 2 week date birth case . For SGE subject : Child care . Hospitalisation unrelated GE . Onset SGE &gt; 48 hour admission ( ED stay ) hospital . Subject digestive tube anomaly , chronic gastrointestinal disease uncorrected congenital abnormality . Subject immunodeficiency . Subjects live federative entity hospital ( ) locate . For Controls : • Subject previously participate case study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Weeks</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Rotarix™</keyword>
	<keyword>Case-control</keyword>
	<keyword>Venezuela</keyword>
	<keyword>Vaccine effectiveness</keyword>
	<keyword>Rotavirus Severe Gastroenteritis</keyword>
	<keyword>Children</keyword>
	<keyword>Hospitalised</keyword>
</DOC>